Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors

计划入组 26 人 · 首次发布于 2021 年 8 月 24 日

A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

计划入组 41 人 · 首次发布于 2018 年 6 月 7 日

Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma

计划入组 400 人 · 首次发布于 2020 年 2 月 21 日

VB10-NEO(Vaccibody AS)

VB10.COV2

Neo-5171

Neo Performance Materials Inc

United States

Neo-Concept International

NEO HEALTH (OTC) PTY LTD

Australia

Nykode Therapeutics Presents Promising Immunotherapy Data for HPV16-Positive Cancer and Solid Tumors at ASCO 2025

Nykode Therapeutics Advances AI-Powered Immunotherapy Platform with Strong Clinical Progress

Immutep's Efti Shows Promise in Neoadjuvant Soft Tissue Sarcoma Treatment